Search
Now showing items 1-1 of 1
The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.
(J Clin Invest, 2007-12)
The clinical utility of anthracycline anticancer agents, especially doxorubicin, is
limited by a progressive toxic cardiomyopathy linked to mitochondrial damage and cardiomyocyte
apoptosis. Here we demonstrate that ...